Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-11

Clinical Trial Update: Nicardipine vs. Labetalol [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing nicardipine with labetalol for acute ischemic stroke and hypertensive crisis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicardipine (nicardipine)
  • labetalol (labetalol hydrochloride)

Snippet

Sponsor: Haseki Training and Research Hospital | Conditions: Acute Ischemic Stroke, Hypertensive Crisis | Phase 4 | Status: COMPLETED